{"id":460455,"date":"2023-05-11T22:05:17","date_gmt":"2023-05-12T05:05:17","guid":{"rendered":"https:\/\/nai500.com\/blog\/2023\/05\/%e6%9c%ac%e5%91%a8%e7%be%8e%e8%82%a1%e6%88%90%e9%95%bf%e8%82%a1%e9%ab%98%e6%ad%8c%e7%8c%9b%e8%bf%9b-3%e5%8f%aa%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e8%82%a1\/"},"modified":"2023-05-11T22:05:27","modified_gmt":"2023-05-12T05:05:27","slug":"%e6%9c%ac%e5%91%a8%e7%be%8e%e8%82%a1%e6%88%90%e9%95%b7%e8%82%a1%e9%ab%98%e6%ad%8c%e7%8c%9b%e9%80%b2-3%e5%8f%aa%e7%94%9f%e7%89%a9%e8%a3%bd%e8%97%a5%e8%82%a1%e7%a5%a8","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2023\/05\/%e6%9c%ac%e5%91%a8%e7%be%8e%e8%82%a1%e6%88%90%e9%95%b7%e8%82%a1%e9%ab%98%e6%ad%8c%e7%8c%9b%e9%80%b2-3%e5%8f%aa%e7%94%9f%e7%89%a9%e8%a3%bd%e8%97%a5%e8%82%a1%e7%a5%a8\/","title":{"rendered":"\u672c\u5468\u7f8e\u80a1\u6210\u9577\u80a1\u9ad8\u6b4c\u731b\u9032\uff0c\u5c24\u5176\u662f\u90193\u53ea\u751f\u7269\u88fd\u85e5\u80a1\u7968"},"content":{"rendered":"<p>\u96d6\u7136\u6d88\u8cbb\u8005\u50f9\u683c\u6307\u6578\uff08CPI\uff09\u518d\u6b21\u4e0d\u5982\u4eba\u610f\uff0c\u5340\u57df\u9280\u884c\u80a1\u7968\u7684\u6ce2\u52d5\u52a0\u5927\uff0c\u4f46\u6574\u9ad4\u4f86\u8aaa\uff0c\u7f8e\u570b\u80a1\u5e02\u7684\u6210\u9577\u578b\u80a1\u7968\u672c\u5468\u4f9d\u7136\u7dad\u6301\u4e0a\u5347\u8da8\u52e2\u3002\u6bd4\u5982\u8aaa\uff0c\u672c\u5468\u524d3\u500b\u534a\u4ea4\u6613\u65e5\u7576\u4e2d\uff0c\u7d0d\u65af\u9054\u514b\u7d9c\u5408\u6307\u6578\u4e0a\u6f32\u8fd13%\uff0c\u5176\u4e2d\u6f32\u52e2\u6700\u731b\u7684\u662f\u751f\u7269\u88fd\u85e5\u80a1\u7968\u3002<\/p>\n<p>\u5177\u9ad4\u4f86\u770b\uff0c\u540c\u671f\u57fa\u56e0\u7de8\u8f2f\u6a19\u6746\u516c\u53f8<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=CRSP\">CRISPR Therapeutics AG\uff08NASDAQ:CRSP\uff09<\/a>\u7684\u80a1\u50f9\u5927\u6f3224.6%\uff0c\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u85e5\u54c1\u958b\u767c\u516c\u53f8BioXcel Therapeutics Inc\uff08NASDAQ:BTAI\uff09\u7684\u80a1\u50f9\u4e0a\u6f3219.8%\uff0c\u57fa\u56e0\u91ab\u85e5\u516c\u53f8Verve Therapeutics Inc\uff08NASDAQ:VERV\uff09\u4e0a\u6f3211%\u3002<\/p>\n<h2>\u90193\u53ea\u751f\u7269\u88fd\u85e5\u80a1\u7968\u70ba\u4f55\u5927\u6f32\uff1f<\/h2>\n<p>CRISPR\u806f\u624b\u798f\u6cf0\u88fd\u85e5Vertex Pharmaceuticals\uff08NASDAQ:VRTX\uff09\u958b\u767c\u7684\u8840\u6db2\u75c5\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5exa-cel\u76ee\u524d\u6b63\u5728\u5be9\u6279\u904e\u7a0b\u4e2d\uff0c\u4e00\u65e6\u7372\u6279\uff0c\u5546\u696d\u524d\u666f\u53ef\u89c0\uff0c\u56e0\u6b64\u9019\u53ea\u751f\u7269\u88fd\u85e5\u80a1\u7968\u7684\u50f9\u683c\u4e00\u76f4\u5728\u7a69\u6b65\u4e0a\u6f32\u3002<\/p>\n<p>\u81f3\u65bcBioXcel Therapeutics\uff0c\u672c\u5468\u8a72\u516c\u53f8\u767c\u4f48\u7684\u4e00\u5b63\u5831\u6574\u9ad4\u7a4d\u6975\uff0c\u5176\u4e2d\u7684\u4eae\u9ede\u662f\u8a72\u751f\u7269\u79d1\u6280\u516c\u53f8\u6700\u91cd\u8981\u7684\u50f9\u503c\u9a45\u52d5\u529bBXCL501\u3002\u5177\u9ad4\u4f86\u8aaa\uff0c\u8a72\u516c\u53f8\u9810\u8a08\u5c07\u5728\u672a\u4f86\u5e7e\u500b\u6708\u5167\u767c\u4f48\u8a72\u85e5\u7269\u6cbb\u7642\u8af8\u5982\u91cd\u5ea6\u6291\u9b31\u75c7\u4ee5\u53ca\u7cbe\u795e\u5206\u88c2\u75c7\u76f8\u95dc\u6fc0\u8d8a\u7b49\u591a\u500b\u9ad8\u50f9\u503c\u9069\u61c9\u75c7\u7684\u8a66\u9a57\u9802\u7dda\u7d50\u679c\u3002\u5982\u679c\u4e00\u5207\u6309\u7167\u8a08\u5283\u63a8\u9032\uff0cBioXCel\u5c07\u64c1\u6709\u771f\u6b63\u7684\u85e5\u7269\u3002<\/p>\n<p>\u9664\u4e86\u5ba3\u4f48\u53c3\u52a05\u670816\u65e5\uff08\u9031\u4e8c\uff09\u8209\u884c\u7684RBC Capital Markets 2023\u5e74\u5168\u7403\u91ab\u7642\u5927\u6703\u4e4b\u5916\uff0cVerve\u672c\u5468\u4e26\u6c92\u6709\u767c\u4f48\u4ec0\u9ebc\u6d88\u606f\uff0c\u56e0\u6b64\u9019\u53ea\u57fa\u56e0\u7d44\u91ab\u5b78\u516c\u53f8\u80a1\u50f9\u7684\u4e0a\u6f32\u57fa\u672c\u5c31\u662f\u8ddf\u96a8CRISPR\u53ca\u5176\u4ed6\u57fa\u56e0\u7642\u6cd5\u516c\u53f8\u7684\u4e0a\u6f32\u3002<\/p>\n<p>\u7e3d\u7684\u4f86\u8aaa\uff0c\u5728\u7d93\u6b772022\u5e74\u718a\u5e02\u5927\u5e45\u56de\u64a4\u5f8c\uff0c\u57fa\u56e0\u7de8\u8f2f\u80a1\u7968\u7684\u50f9\u683c\u4eca\u5e74\u4e00\u76f4\u5728\u53cd\u5f48\u3002\u591a\u5bb6\u516c\u53f8\u5373\u5c07\u5ba3\u4f48\u8a72\u9818\u57df\u7684\u91cd\u5927\u91cc\u7a0b\u7891\uff0c\u9019\u5438\u5f15\u6295\u8cc7\u8005\u91cd\u73fe\u570d\u7e5e\u5230\u9019\u4e9b\u80a1\u50f9\u5df2\u7d93\u5927\u8dcc\u7684\u80a1\u7968\u5468\u570d\u3002<\/p>\n<h2>\u9019\u4e9b\u71b1\u9580\u7684\u7d0d\u6307\u80a1\u7968\u9084\u503c\u5f97\u8cb7\u5165\u55ce\uff1f<\/h2>\n<p>\u5728\u90193\u53ea\u751f\u7269\u88fd\u85e5\u80a1\u7968\u7576\u4e2d\uff0cCRISPR\u812b\u7a4e\u800c\u51fa\uff0c\u4f9d\u64da\u5305\u62ec\u8a72\u516c\u53f8\u64c1\u6709\u8fd120\u5104\u7f8e\u5143\u7684\u73fe\u91d1\uff0c\u8fc5\u901f\u6210\u9577\u7684\u514d\u75ab\u816b\u7624\u548c\u7f55\u898b\u75c5\u5728\u7814\u85e5\u7269\u7ba1\u7dda\uff0c\u4ee5\u53ca\u8a72\u516c\u53f8\u8207\u798f\u6cf0\u88fd\u85e5\u7684\u5408\u4f5c\u53ef\u4ee5\u5927\u5927\u6e1b\u8f15exa-cel\u7b49\u65b0\u85e5\u4e0a\u5e02\u7684\u58d3\u529b\u3002<\/p>\n<p>\u4f46\u662f\uff0c\u9019\u4e26\u4e0d\u610f\u5473\u8457BioXcel\u548cVerve\u4e0d\u6703\u6210\u529f\uff0c\u800c\u662f\u8aaa\u9019\u5169\u5bb6\u516c\u53f8\u9084\u9700\u8981\u66f4\u52a0\u52aa\u529b\u5730\u5411\u5b83\u5011\u7684\u80a1\u6771\u8b49\u660e\u81ea\u5df1\u7684\u6838\u5fc3\u50f9\u503c\u4e3b\u5f35\u3002\u76f8\u6bd4\u4e4b\u4e0b\uff0cCRISPR\u6709\u53ef\u80fd\u5373\u5c07\u6210\u70ba\u7b2c\u4e00\u5bb6\u5c07\u57fa\u56e0\u7de8\u8f2f\u7522\u54c1\u4e0a\u5e02\u7684\u516c\u53f8\u3002<\/p>\n<p><audio style=\"display: none;\" controls=\"controls\"><\/audio><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u96d6\u7136\u6d88\u8cbb\u8005\u50f9\u683c\u6307\u6578\uff08CPI\uff09\u518d\u6b21\u4e0d\u5982\u4eba\u610f\uff0c\u5340\u57df\u9280\u884c\u80a1\u7968\u7684\u6ce2\u52d5\u52a0\u5927\uff0c\u4f46\u6574\u9ad4\u4f86\u8aaa\uff0c\u7f8e\u570b\u80a1\u5e02\u7684\u6210\u9577\u578b\u80a1\u7968\u672c\u5468\u4f9d\u7136\u7dad\u6301 [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":451609,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[809,927,563,564],"class_list":["post-460455","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-809","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/460455","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=460455"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/460455\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/451609"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=460455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=460455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=460455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}